Dáil Éireann Debate, Tuesday - 26 January 2016
370. Deputy Gerry Adams asked the Minister for Health the criteria persons must meet in order to be approved for use of Fampyra under the long-term illness scheme; the average waiting time for approval; the mechanisms through which persons can actively pursue approval or determine reasons for refusal for this treatment; and if he will make a statement on the matter. [3135/16]
View answerAs you are aware, Fampridine (brand name Fampyra®) has been reimbursed under the Long Term Illness Scheme on a conditional, responder-only basis since 1 October 2015.
Reimbursement will be extended where a demonstration of clinical response (based on objective criteria agreed with clinical experts) is recorded and where that clinical response is shown to persist, based on objective measurement at six-monthly intervals.
I have arranged for your questions regarding the application process and waiting times to be referred to the HSE for direct reply. If the Deputy has not received a reply from the HSE within 15 working days, please contact my Private Office and they will follow up the matter with them.
